Personalized Medicine in Ophthalmic Diseases: Challenges and Opportunities

Kai Jin,Chun Zhang

DOI: https://doi.org/10.3390/jpm13060893

IF: 3.5083

2023-01-01

Journal of Personalized Medicine

Abstract:Personalized medicine is a broadly used term to encompass approaches used to tailor healthcare to the needs of individual patients [...].

What problem does this paper attempt to address?

Opportunities and Challenges of Laboratory Medicine Based on Personalized Information in Precision ;Medicine

Zhang Jun,Xie Xinyou

DOI: https://doi.org/10.3760/cma.j.issn.1009-9158.2016.09.001

2016-01-01

Abstract:Since 2015, US government announced the Precision Medicine Initiative, the concept of“precision medicine” is spreading rapidly, which has seemingly become the mainstream of future medicine.Laboratory medicine based on personalized information brought by the development of precision medicine will be an entirely new area, however its complexity is far beyond the current knowledge and laboratory medical scientists are encouraged to be actively involved in this emerging field.Opportunities and challenges may coexist, which mainly include: screening and evaluation of circulating biomarkers, selection and standardization of appropriate molecular diagnostic techniques, acquisition of high quality biological specimens and establishment of sample library, and comprehensive interpretation of the results in order to achieve and improve individualized precise prevention, diagnosis, and treatment for specific diseases and patients.
Molecular Eye: A System for Precise Diagnosis and Treatment of Major Clinical Diseases Based on Molecular Probe Technology

Xin Ji,Xin Chen,Kexin Li,Zhihao Zhang,Lijun Tang,Tiannv Li,Feng Han,Hao Hong,Tao Zhang

DOI: https://doi.org/10.1021/cbmi.3c00093

2023-01-01

Abstract:With the flourishing development of precision medicine, theranostics, generally recognized as the integration of diagnosis and treatment, has emerged as a prominent trend in clinical research. However, theranostics primarily emphasizes the end result of integration, without providing sufficient details on how precise diagnosis and synergetic individualized treatment could be achieved and what clinical challenges could be effectively addressed in clinical practice. Molecular probe technology provides a robust method to bridge the gap between theory and practice. Through meticulous design of the chemical structure, imaging labels or drugs were conjugated to tumor-targeting peptides, antibodies, or inducers to form molecular probes, which allow a seamless switch between targeted intervention and targeted imaging with consistency in time, space, and biodistribution. Thus, this review proposes a concept called "molecular eye", which refers to a comprehensive system for precise diagnosis and treatment of major clinical diseases based on molecular probe technology. This medical system emphasizes the chemical basis of probe development and optimization, which can provide precise actionable information for clinical decision making, allow molecular-targeted therapy, expand the indications of old therapy, and accelerate the regulatory approval of molecular drugs. "Molecular eye" resembles the piercing eye of the Monkey King, which can detect previously "invisible" diseases and facilitate disease diagnosis, treatment, real-time evaluation, and pathology research, guiding drug development. The emergence of the "molecular eyes" will provide opportunities and challenges in the fields of clinical practice and medical research and propel the progression of contemporary medicine toward precision medicine.
Personalized Cancer Therapy Using a Patient-Derived Tumor Tissue Xenograft Model: a Translational Field Worthy of Exploring Further?

Ketao Jin,Kuifeng He,Guangliang Li,Lisong Teng

DOI: https://doi.org/10.2217/pme.10.48

2010-01-01

Personalized Medicine

Abstract:It has long been observed that interpatient variability in response to anticancer drugs is associated with different outcomes. Oncologists continually hold the desire of matching the right therapeutic regimen with the right cancer patient, which is termed 'personalized cancer therapy'. Rapid advances in genetics, genomics and related technologies are promising a new era of personalized cancer therapy based on individual molecular biomarkers. However, these molecular predictors of tumor response are far from perfect. Because of the inherent limitations in the current approaches for anticancer drugs response prediction, the need for new techniques to predict tumor response to therapy is urgent. Using a patient-derived human tumor tissue (PDTT) xenograft model to predict tumor response to therapy might be an ideal candidate method to choose. This article provides an overview of the achievements and limitations of genetic, genomic and proteomic molecular markers for personalized cancer therapy, and further discusses the potentials of using a PDTT xenograft model as a candidate strategy for personalized cancer therapy.
Personalized drugs: a new opportunity for translational research

GUO Ting,TANG Juan,CHEN Zhi-nan

DOI: https://doi.org/10.3969/j.issn.2095-3097.2013.02.001

2013-01-01

Abstract:The key point of medical mode conversion and reform has been dominated by the treatment of traditional disease gradually to transfer for health promotion,namely the establishment of a new health care idea for human life composed preventive medicine,predictive medicine and individual prescription for medical intervention.This paper discusses the effect of the drug treatment related factors,personalize drug usage,and pharmacogenomics.For example of personalized medicine,to develop the gene targeted drugs for cancer is necessary.
Enabling Technologies for Personalized and Precision Medicine.

Dean Ho,Stephen R Quake,Edward R B McCabe,Wee Joo Chng,Edward K Chow,Xianting Ding,Bruce D Gelb,Geoffrey S Ginsburg,Jason Hassenstab,Chih-Ming Ho,William C Mobley,Garry P Nolan,Steven T Rosen,Patrick Tan,Yun Yen,Ali Zarrinpar

DOI: https://doi.org/10.1016/j.tibtech.2019.12.021

2020-01-01

Trends in Biotechnology

Abstract:Individualizing patient treatment is a core objective of the medical field. Reaching this objective has been elusive owing to the complex set of factors contributing to both disease and health; many factors, from genes to proteins, remain unknown in their role in human physiology. Accurately diagnosing, monitoring, and treating disorders requires advances in biomarker discovery, the subsequent development of accurate signatures that correspond with dynamic disease states, as well as therapeutic interventions that can be continuously optimized and modulated for dose and drug selection. This work highlights key breakthroughs in the development of enabling technologies that further the goal of personalized and precision medicine, and remaining challenges that, when addressed, may forge unprecedented capabilities in realizing truly individualized patient care.
Reflection on ethics of gene-oriented personalized medicine

Yan LU,Zong-ying JIANG,Zu-cong CAO,Xiao-mei CAO,Tai-ming LI,Guo-bin YANG,Guo-hua ZHOU

DOI: https://doi.org/10.13699/j.cnki.1001-6821.2015.02.017

2015-01-01

Abstract:Gene-oriented personalized medicine is an inevitable tendency for clinical medication in the future , but a series of ethical issues may a-rise during clinical promotion and application.Personalized medicine may vary from individual patient , molecular character of disease , and drugs used in the treatment.Therefore , in this paper , personalized medicine -related ethical issues arising from the above three aspects were described and discussed respectively in combination with specific clinical examples .Targeted recommendations were put forward in this paper .
Personalized Medicine in Brain Tumors

Quintino Giorgio D’Alessandris,Martina Offi,Liverana Lauretti,Roberto Pallini,Quintino Giorgio D'Alessandris

DOI: https://doi.org/10.3390/jpm14040413

IF: 3.5083

2024-04-13

Journal of Personalized Medicine

Abstract:Personalizing clinical, diagnostic and therapeutic approaches in neuro-oncology is a huge challenge [...]

medicine, general & internal,health care sciences & services
[Emphasis on the Application of Precision Medicine in Ophthalmology].

X D Sun,H Zhu

DOI: https://doi.org/10.3760/cma.j.issn.0412-4081.2016.02.002

2016-01-01

Abstract:Accompany with dramatically growth of large-scale biological databases (such as human genome sequence), improvement of life science and development of international clinical trials, science offers great potential for improving health care through precision medicine. As a hot topic recently, precision medicine might launch a revolution of the methodology in medical research. How to achieve precision medicine in clinical ophthalmology by means of biological data mining is a challenge for ophthalmologist-scientists. The best approach for advanced individual medicine is to buildup the digital ophthalmology, which includes human eye biobank, national biological databases network, clinical department, basic research lab, and international clinical trial center. The system of digital ophthalmology could explore the methods for ophthalmology research, integrate the source of eye biologic databases, promote international cooperation, and thus eventually supply the opportunity for translational medicine.
Personalized Precision Diagnosis and Therapy：Development and Challenge in Clinic

Xinran ZHANG,Yingwei FAN,Hongen LIAO

DOI: https://doi.org/10.3969/j.issn.1674-1633.2016.03.002

2016-01-01

Abstract:Personalized precision diagnosis and therapy provide an accurate, minimally invasive and effective approach for clinical diagnostic and therapeutic platform for complex diseases, which has great research and clinical value. Accurate diagnosis techniques are important preconditions of personalized therapy. This paper reviewed the most recent achievements and major methods of personalized precision diagnosis, medical information fusion, and visualization techniques. Developments and challenges of personalized precision diagnosis and therapy fully relfects its broad prospects in clinical trials. Continued improvements of personalized precision diagnosis will lead to better understanding of mechanisms of diseases and will play an important role in the treatment and cure of critical illnesses. Meanwhile it will also accelerate the trend of integration of intelligent minimal invasiveness diagnosis and therapy.
Organoids‐On‐a‐Chip for Personalized Precision Medicine

Yunqi Man,Yanfei Liu,Qiwen Chen,Zhirou Zhang,Mingfeng Li,Lishang Xu,Yifu Tan,Zhenbao Liu

DOI: https://doi.org/10.1002/adhm.202401843

IF: 10

2024-10-15

Advanced Healthcare Materials

Abstract:Recently, organoids‐on‐a‐chip have become a promising focus in the development of personalized precision medicine. This review provides an overview of the application and prospects of organoids‐on‐a‐chip in personalized precision medicine, including treatment optimization, drug screening, disease modeling, and other aspects. This review summarizes this area of research and suggests future research directions. The development of personalized precision medicine has become a pivotal focus in modern healthcare. Organoids‐on‐a‐Chip (OoCs), a groundbreaking fusion of organoid culture and microfluidic chip technology, has emerged as a promising approach to advancing patient‐specific treatment strategies. In this review, the diverse applications of OoCs are explored, particularly their pivotal role in personalized precision medicine, and their potential as a cutting‐edge technology is highlighted. By utilizing patient‐derived organoids, OoCs offer a pathway to optimize treatments, create precise disease models, investigate disease mechanisms, conduct drug screenings, and individualize therapeutic strategies. The emphasis is on the significance of this technological fusion in revolutionizing healthcare and improving patient outcomes. Furthermore, the transformative potential of personalized precision medicine, future prospects, and ongoing advancements in the field, with a focus on genomic medicine, multi‐omics integration, and ethical frameworks are discussed. The convergence of these innovations can empower patients, redefine treatment approaches, and shape the future of healthcare.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Personalized Treatment Approaches in Intraocular Cancer

Yating Liu,Alexander C. Rokohl,Yongwei Guo,Ke Yao,Wanlin Fan,Ludwig M.

DOI: https://doi.org/10.1016/j.aopr.2024.03.005

2024-01-01

Advances in Ophthalmology Practice and Research

Abstract:BackgroundIntraocular malignant tumors represent a severe disease that threatens vision as well as life. To better extend the life of the patient, preserve visual function, and maintain ocular aesthetics, selecting the appropriate timing and methods of treatment becomes crucial.Main textWith the continuous advancement of medical technology, the techniques and methods for treating intraocular malignant tumors are constantly evolving. While surgery was once considered the optimal method to prolong patient survival and prevent local recurrence, the discovery and application of various treatments such as radiotherapy, laser therapy, chemotherapy, cryotherapy, and monoclonal antibodies have led to a greater diversity of treatment options. This diversity offers more possibilities to develop personalized treatment plans, and thereby maximize patient benefit. This article reviews the various treatment methods for intraocular malignant tumors, including indications for treatment, outcomes, and potential complications.ConclusionsDifferentiating small intraocular malignant tumors from pigmented lesions is challenging, and ongoing monitoring with regular follow-up is required. Small to medium-sized tumors can be treated with radiotherapy combined with transpupillary thermotherapy. Depending on the tumor's distance from the optic disc, surgery with partial resection may be considered for distant tumors, while proximal tumors may require complete enucleation. Systemic chemotherapy has been widely applied to patients with retinal tumors, lymphomas, and intraocular metastatic cancers, but has limited efficacy in patients with choroidal melanoma. Antagonists of Vascular Endothelial Growth Factor (Anti-VEGF) drugs can improve patient vision and quality of life, while the efficacy of immunotherapy and molecular targeted therapy is still under research.
Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectives

Qinghua Lyu,Ling Peng,Xiangqian Hong,Taojian Fan,Jingying Li,Yubo Cui,Han Zhang,Jun Zhao

DOI: https://doi.org/10.1016/j.biomaterials.2021.120682

IF: 14

2021-03-01

Biomaterials

Abstract:<p>Smart nano-micro platforms have been extensively applied for diverse biomedical applications, mostly focusing on cancer therapy. In comparison with conventional nanotechnology, the smart nano-micro matrix can exhibit specific response to exogenous or endogenous triggers, and thus can achieve multiple functions e.g. site-specific drug delivery, bio-imaging and detection of bio-molecules. These intriguing techniques have expanded into ophthalmology in recent years, yet few works have been summarized in this field. In this work, we provide the state-of-the-art of diverse nano-micro platforms based on both the conventional materials (e.g. natural or synthetic polymers, lipid nanomaterials, metal and metal oxide nanoparticles) and emerging nanomaterials (e.g. up-conversion nanoparticles, quantum dots and carbon materials) in ophthalmology, with some smart nano/micro platformers highlighted. The common ocular diseases studied in the field of nano-micro systems are firstly introduced, and their therapeutic method and the related drawback in clinic treatment are presented. The recent progress of different materials for diverse ocular applications is then demonstrated, with the representative nano- and micro-systems highlighted in detail. At last, an in-depth discussion on the clinical translation challenges faced in this field and the future direction are provided. This review would allow the researchers to design more smart nanomedicines in a more rational manner for specific ophthalmology applications.</p>

engineering, biomedical,materials science, biomaterials
Personalized treatment concepts in extraocular cancer

Sitong Ju,Alexander C Rokohl,Yongwei Guo,Ke Yao,Wanlin Fan,Ludwig M Heindl

DOI: https://doi.org/10.1016/j.aopr.2024.02.003

2024-03-01

Abstract:Background: The periocular skin is neoplasms-prone to various benign and malignant. Periocular malignancies are more aggressive and challenging to cure and repair than those in other skin areas. In recent decades, immunotherapy has significantly advanced oncology, allowing the autoimmune system to target and destroy malignant cells. Skin malignancies, especially periocular tumors, are particularly sensitive to immunotherapy. This technique has dramatically impacted the successful treatment of challenging tumors. Main text: Extraocular cancers, including eyelid (basal cell carcinoma, squamous cell carcinoma, melanoma, merkel cell carcinoma), conjunctival tumors (conjunctival melanoma, ocular surface squamous neoplasia) and other rare tumors, are unique and challenging clinical situations. Several genetic alterations associated with the pathogenesis of these diseases have been identified, and molecular mechanism are essential for the development of the immunotherapy agents, such as Hedgehog pathway inhibitors (vismodegib and sonidegib) for basal cell carcinoma, BRAF/MEK inhibitors (vemurafenib, dabrafenib, and encorafenib) for melanoma, and immune checkpoint inhibitors (Avelumab, pembrolizumab) for Merkel cell carcinoma. Conclusions: The optimal treatment for periocular skin cancer depends on the type and size of the tumor and whether it involves orbital and adnexal structures. Adjuvant and neoadjuvant therapy with chemotherapy-targeted therapies and immune checkpoint inhibitors should be considered based on tumor type, tumor molecular profile, expected response rate, and candidacy for systemic treatment.
Personalized drug therapy: innovative concept guided with proteoformics

Junwen Su,Lamei Yang,Ziran Sun,Xianquan Zhan

DOI: https://doi.org/10.1016/j.mcpro.2024.100737

IF: 7.381

2024-02-16

Molecular & Cellular Proteomics

Abstract:Personalized medicine can reduce adverse effects, enhance drug efficacy, and optimize treatment outcomes, which represents the essence of personalized medicine in the pharmacy field. Protein drugs are crucial in the field of personalized drug therapy and are currently the mainstay, which possess higher target specificity and biological activity compared to small-molecule chemical drugs, making them efficient in regulating disease-related biological processes, and have significant potential in...

biochemical research methods
Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach

Aihua Zhang,Hui Sun,Ping Wang,Ying Han,Xijun Wang

DOI: https://doi.org/10.1016/j.ctim.2011.10.007

IF: 3.335

2012-02-01

Complementary Therapies in Medicine

Abstract:Deconstruction of molecular pathways and advances in enabling technology platforms have opened new horizons for disease management, exploring therapeutic solutions to each individual patient beyond the one-size fits all practice. Application of personalized medicine paradigms aims to achieve the right diagnosis and right treatment for the right patient at the right time at the right cost. With the potential to transform medical practice across global communities, personalized medicine is emerging as the flagship of modern medicine. In recent years, the health care paradigm has shifted from a focus on diseases to a major hot of personalized traditional Chinese medicine (TCM) with holistic approach. TCM focuses on health maintenance, emphasizes on enhancing the body's resistance to diseases and especially showes great advantages in early intervention, personalized and combination therapies, etc. Systems biology, a new science of the 21st century, becomes practically available and resembles TCM in many aspects such as study method and design, and is current key component technologies that serves as the major driving force for translation of the personalized medicine revolution of TCM principles into practice, will advance personalized therapy principles into healthcare management tools for individuals and populations. Such system approach concepts are transforming principles of TCM to modern therapeutic approaches, enable a predictive and preventive medicine and will lead to personalized medicine. To realise the full potential of personalized TCM, we describe the current status of principles and practice of TCM integrated with systems biology platform. Some characteristic examples are presented to highlight the application of this platform to personalized TCM research and development as well as some of the necessary milestones for moving TCM into mainstream health care.

integrative & complementary medicine
Ocular Nanomedicine (adv. Sci. 15/2022)

Zhimin Tang,Xianqun Fan,Yu Chen,Ping Gu

DOI: https://doi.org/10.1002/advs.202270099

IF: 15.1

2022-01-01

Advanced Science

Abstract:Ocular Nanomedicine In article number 2003699, Zhimin Tang, Xianqun Fan, Yu Chen, and Ping Gu comprehensively overview the distinctive functional ocular nanomedicine as potential alternatives for multipurpose ocular applications. By affording insight into challenges encountered by ocular nanomedicine and further highlighting the direction of future studies, this review provides an incentive for enriching ocular nanomedicine-based fundamental research and future clinical translation.
Ocular Nanomedicine

Zhimin Tang,Xianqun Fan,Yu Chen,Ping Gu

DOI: https://doi.org/10.1002/advs.202003699

IF: 15.1

2022-02-12

Advanced Science

Abstract:Intrinsic shortcomings associated with conventional therapeutic strategies often compromise treatment efficacy in clinical ophthalmology, prompting the rapid development of versatile alternatives for satisfactory diagnostics and therapeutics. Given advances in material science, nanochemistry, and nanobiotechnology, a broad spectrum of functional nanosystems has been explored to satisfy the extensive requirements of ophthalmologic applications. In the present review, the recent progress in nanosystems, both conventional and emerging nanomaterials in ophthalmology from state-of-the-art studies, are comprehensively examined and the role of their fundamental physicochemical properties in bioavailability, tissue penetration, biodistribution, and elimination after interacting with the ophthalmologic microenvironment emphasized. Furthermore, along with the development of surface engineering of nanomaterials, emerging theranostic methodologies are promoted as potential alternatives for multipurpose ocular applications, such as emerging biomimetic ophthalmology (e.g., smart electrochemical eye), thus provoking a holistic review of "ocular nanomedicine." By affording insight into challenges encountered by ocular nanomedicine and further highlighting the direction of future studies, this review provides an incentive for enriching ocular nanomedicine-based fundamental research and future clinical translation.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products

Yalan Zhou,Siqi Peng,Huizhen Wang,Xinyin Cai,Qingzhong Wang

DOI: https://doi.org/10.3390/genes15040468

2024-04-08

Abstract:In recent years, the FDA has approved numerous anti-cancer drugs that are mutation-based for clinical use. These drugs have improved the precision of treatment and reduced adverse effects and side effects. Personalized therapy is a prominent and hot topic of current medicine and also represents the future direction of development. With the continuous advancements in gene sequencing and high-throughput screening, research and development strategies for personalized clinical drugs have developed rapidly. This review elaborates the recent personalized treatment strategies, which include artificial intelligence, multi-omics analysis, chemical proteomics, and computation-aided drug design. These technologies rely on the molecular classification of diseases, the global signaling network within organisms, and new models for all targets, which significantly support the development of personalized medicine. Meanwhile, we summarize chemical drugs, such as lorlatinib, osimertinib, and other natural products, that deliver personalized therapeutic effects based on genetic mutations. This review also highlights potential challenges in interpreting genetic mutations and combining drugs, while providing new ideas for the development of personalized medicine and pharmacogenomics in cancer study.
Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes

Mariano Bizzarri,Valeria Fedeli,Noemi Monti,Alessandra Cucina,Maroua Jalouli,Saleh H Alwasel,Abdel Halim Harrath

DOI: https://doi.org/10.1007/s13167-021-00254-1

2021-10-07

Abstract:The agenda of pharmacology discovery in the field of personalized oncology was dictated by the search of molecular targets assumed to deterministically drive tumor development. In this perspective, genes play a fundamental "causal" role while cells simply act as causal proxies, i.e., an intermediate between the molecular input and the organismal output. However, the ceaseless genomic change occurring across time within the same primary and metastatic tumor has broken the hope of a personalized treatment based only upon genomic fingerprint. Indeed, current models are unable in capturing the unfathomable complexity behind the outbreak of a disease, as they discard the contribution of non-genetic factors, environment constraints, and the interplay among different tiers of organization. Herein, we posit that a comprehensive personalized model should view at the disease as a "historical" process, in which different spatially and timely distributed factors interact with each other across multiple levels of organization, which collectively interact with a dynamic gene-expression pattern. Given that a disease is a dynamic, non-linear process - and not a static-stable condition - treatments should be tailored according to the "timing-frame" of each condition. This approach can help in detecting those critical transitions through which the system can access different attractors leading ultimately to diverse outcomes - from a pre-disease state to an overt illness or, alternatively, to recovery. Identification of such tipping points can substantiate the predictive and the preventive ambition of the Predictive, Preventive and Personalized Medicine (PPPM/3PM). However, an unusual effort is required to conjugate multi-omics approaches, data collection, and network analysis reconstruction (eventually involving innovative Artificial Intelligent tools) to recognize the critical phases and the relevant targets, which could help in patient stratification and therapy personalization.
Personalised Medicine: Taking a New Look at the Patient

Marco Scutari

DOI: https://doi.org/10.48550/arXiv.1401.2649

2014-01-13

Abstract:Personalised medicine strives to identify the right treatment for the right patient at the right time, integrating different types of biological and environmental information. Such information come from a variety of sources: omics data (genomic, proteomic, metabolomic, etc.), live molecular diagnostics, and other established diagnostics routinely used by medical doctors. Integrating these different kinds of data, which are all high-dimensional, presents significant challenges in knowledge representation and subsequent reasoning. The ultimate goal of such a modelling effort is to elucidate the flow of information that links genes, protein signalling and other physiological responses to external stimuli such as environmental conditions or the progress of a disease.

Applications

Personalized Medicine in Ophthalmic Diseases: Challenges and Opportunities

Opportunities and Challenges of Laboratory Medicine Based on Personalized Information in Precision ;Medicine

Molecular Eye: A System for Precise Diagnosis and Treatment of Major Clinical Diseases Based on Molecular Probe Technology

Personalized Cancer Therapy Using a Patient-Derived Tumor Tissue Xenograft Model: a Translational Field Worthy of Exploring Further?

Personalized drugs: a new opportunity for translational research

Enabling Technologies for Personalized and Precision Medicine.

Reflection on ethics of gene-oriented personalized medicine

Personalized Medicine in Brain Tumors

[Emphasis on the Application of Precision Medicine in Ophthalmology].

Personalized Precision Diagnosis and Therapy：Development and Challenge in Clinic

Organoids‐On‐a‐Chip for Personalized Precision Medicine

Personalized Treatment Approaches in Intraocular Cancer

Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectives

Personalized treatment concepts in extraocular cancer

Personalized drug therapy: innovative concept guided with proteoformics

Future perspectives of personalized medicine in traditional Chinese medicine: A systems biology approach

Ocular Nanomedicine (adv. Sci. 15/2022)

Ocular Nanomedicine

Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products

Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes

Personalised Medicine: Taking a New Look at the Patient